Loading video...
Video Failed to Load
In conversation with Andrew D. Huberman, Ph.D., Peter Attia explains why ApoB should be treated as a causal driver of heart disease, not just a risk marker: “There is no ambiguity that ApoB is causally related to atherosclerosis.” “LDL cholesterol or ApoB, causally related to atherosclerosis. Well, if that’s... show more
212,256 views • 10 months ago •via X (Twitter)
0 Comments
No comments available
Comments from the original post will appear here

